Cargando…
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission
Transmission-blocking interventions can play an important role in combating malaria worldwide. Recently, a highly potent Plasmodium falciparum transmission-blocking monoclonal antibody (TB31F) was demonstrated to be safe and efficacious in malaria-naive volunteers. Here we predict the potential publ...
Autores principales: | Challenger, Joseph D, van Beek, Stijn W, ter Heine, Rob, van der Boor, Saskia C, Charles, Giovanni D, Smit, Merel J, Ockenhouse, Chris, Aponte, John J, McCall, Matthew B B, Jore, Matthijs M, Churcher, Thomas S, Bousema, Teun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345482/ https://www.ncbi.nlm.nih.gov/pubmed/37042518 http://dx.doi.org/10.1093/infdis/jiad101 |
Ejemplares similares
-
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults
por: van der Boor, Saskia C, et al.
Publicado: (2022) -
Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes
por: de Jong, Roos M., et al.
Publicado: (2021) -
Heterologous Expression and Evaluation of Novel Plasmodium falciparum Transmission Blocking Vaccine Candidates
por: de Jong, Roos M., et al.
Publicado: (2022) -
Human immune responses that reduce the transmission of Plasmodium falciparum in African populations
por: Bousema, Teun, et al.
Publicado: (2011) -
Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
por: Stone, Will, et al.
Publicado: (2022)